EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $452 | +1.6% | 20,682 | -11.1% | 0.03% | -2.9% |
Q2 2023 | $445 | -0.9% | 23,263 | +0.5% | 0.04% | +6.1% |
Q1 2023 | $449 | +4.4% | 23,153 | -13.6% | 0.03% | -8.3% |
Q4 2022 | $430 | -99.9% | 26,803 | +0.7% | 0.04% | -7.7% |
Q3 2022 | $417,000 | -17.1% | 26,611 | +10.2% | 0.04% | -15.2% |
Q2 2022 | $503,000 | +73.4% | 24,138 | +88.9% | 0.05% | +411.1% |
Q1 2022 | $290,000 | +53.4% | 12,780 | +23.3% | 0.01% | +28.6% |
Q4 2021 | $189,000 | – | 10,364 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |